Aug 14 (Reuters)-
Cyfuse Biomedical K.K.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2026 Jun 30, 2025 Dec 31, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 104 mln 29 mln 278 mln
(+254.6 pct) (+63.1 pct) (+20.4 pct)
Operating loss 417 mln loss 471 mln loss 1.08
Recurring loss 433 mln loss 401 mln loss 1.06
Net loss 434 mln loss 402 mln loss 1.06
EPS loss 43.46 yen loss 48.86 yen loss 110.22 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Cyfuse Biomedical K.K..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4892.T